ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

LGND Ligand Pharmaceuticals Incorporated

73.10
1.83 (2.57%)
Mar 28 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Ligand Pharmaceuticals Incorporated LGND NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
1.83 2.57% 73.10 20:00:00
Open Price Low Price High Price Close Price Prev Close
71.29 71.12 73.42 73.10 71.27
more quote information »

Recent News

Date Time Source Heading
3/07/202413:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/06/202417:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202418:12EDGAR2Form 144 - Report of proposed sale of securities
3/01/202416:09EDGAR2Form S-8 - Securities to be offered to employees in employee..
2/29/202418:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/29/202418:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/29/202418:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/29/202418:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/29/202416:49EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
2/28/202418:05EDGAR2Form 144 - Report of proposed sale of securities
2/28/202417:43EDGAR2Form 144 - Report of proposed sale of securities
2/27/202407:24EDGAR2Form 8-K - Current report
2/16/202420:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/16/202420:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/16/202420:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/16/202420:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/14/202406:26EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/13/202415:39EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/10/202419:30GLOBEHenlius and Sermonix Announce Strategic Collaboration and..
1/05/202417:40DJNLigand Pharmaceuticals Gets FDA OK for Viral Skin Infection..
1/04/202416:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/06/202315:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/06/202315:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/01/202308:25EDGAR2Form 8-K - Current report
12/01/202308:20GLOBEPalvella Therapeutics and Ligand Pharmaceuticals Expand..
11/28/202309:01GLOBESermonix Pharmaceuticals Announces Five Abstracts Accepted..
11/09/202321:48EDGAR2Form 8-K/A - Current report: [Amend]
11/09/202317:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/08/202316:08EDGAR2Form 8-K - Current report
11/06/202309:00GLOBESermonix Pharmaceuticals Announces JCO Precision Oncology..
10/18/202309:03EDGAR2Form 8-K - Current report
10/18/202308:00GLOBEOvid Therapeutics and Ligand Pharmaceuticals Enter into a..
10/03/202316:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/02/202309:00GLOBESermonix Pharmaceuticals Shares Results of EQUALS 2 Survey..
9/27/202308:38EDGAR2Form 8-K - Current report
9/26/202316:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/25/202316:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/18/202317:26EDGAR2Form 8-K - Current report
8/14/202316:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/09/202316:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/08/202316:02EDGAR2Form 8-K - Current report
7/17/202308:45GLOBENovan Enters into Agreement to Sell Substantially All of its..
7/10/202318:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/10/202318:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/29/202309:00GLOBESermonix Pharmaceuticals to Present Two Posters at The..
6/05/202309:01GLOBESermonix Pharmaceuticals Shares ASCO Poster Presentation on..
5/25/202317:00GLOBESermonix Pharmaceuticals to Share Longer Patient Follow-up..

Your Recent History

Delayed Upgrade Clock